Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST).
Melissa CoffmanEmilie GuillotThomas BlondelCatherine Garelli-PaarShuo FengSusanne HeartsillClarke E AtkinsPublished in: Journal of veterinary internal medicine (2021)
The combination of S+BNZ is effective, safe, and superior to benazepril alone, when used with furosemide for the management of mild, moderate or severe CHF caused by MMVD in dogs.